These compounds may interact with:

Interleukin-1 receptor-associated kinase 4

Potentially involved in: carcinoma; meningitis; adenosine deaminase deficiency; immunologic deficiency syndromes; prostatic neoplasms; hypoxia-ischemia, brain; neutrophil count decreased; invasive pneumococcal disease, recurrent isolated, 1; irak4 deficiency; recurrent streptococcus pneumoniae infections; autosomal recessive predisposition; recurrent staphylococcal infections; immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency; malignant mesothelioma; disease models, animal; lupus erythematosus, systemic

Disease data sourced from Pharos.